SciRhom GmbH is a pioneering biotech enterprise focused on developing first-in-class humanized antibodies against iRhom2 for the treatment of autoimmune diseases, including rheumatoid arthritis and inflammatory bowel disease
SciRhom GmbH is a pioneering biotech enterprise focused on developing first-in-class humanized antibodies against iRhom2 for the treatment of autoimmune diseases, including rheumatoid arthritis and inflammatory bowel disease.